Laboratory services

Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 221
A002 Cell Blood Count 27 1 850
A005 Sedimentation rate 16 1 097
A008 Reticulocytes 13 891
A009 Matching of blood and compatibility test 320 21 931
M125 Malaria test 67 4 592
URINE ANALYSIS
B500 Standard urine test 13 891
B502 Standard urine test with microscopy 24 1 645
B510 Urine pregnancy test (screening) 13 891
B511 Nechiporenko urine test 20 1 371
B512 Zimnitsky urine test 53 3 632
B513 3-portions urine test examination 40 2 741
B514 2-portions urine test examination 27 1 850
B515 Urine precipitate - Microscopy 13 891
B517 Creatinine Clearance 53 3 632
STOOL ANALYSIS
B306 Fecal examination for pancreatic elastase-1 55 3 769
M105 Coprology total 27 1 850
M110 Coprology (occult blood) 13 891
M111 Carbohydrates in faeces 40 2 741
M115 Enterobiasis 20 1 371
M120 Eggs of helminths (+protozoa) 27 1 850
M122 Protozoa in faeces 20 1 371
M390 Adenovirus and rotavirus (in stool) 28 1 919
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 2 810
M391 Helicobacter pylori(in stool) 27 1 850
M393 Verotoxin in stool 50 3 427
M394 Norovirus in stool 25 1 713
M395 Calprotectin in stool (quantitative) 53 3 632
M396 Clostridium Difficile Toxin A & B 65 4 455
SPUTUM ANALYSIS
M150 Standard sputum test 27 1 850
M002 Nasal slime general clinical research 27 1 850
M355 M. Tuberculosis in sputum 33 2 262
SKIN& NAIL PLATES
M126 Microscopic examination of a scraping from the skin, papules and ulcers on the edges parasitos 18 1 234
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 221
M210 Demodex folliculorum 20 1 371
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 280
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 371
M221 Standard Cervical Smear Test 20 1 371
M222 Standard Urethral Smear Test 20 1 371
M223 Standard prostatic fluid test 27 1 850
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 1 850
B621 Standard Serous Fluid test 27 1 850
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 262
B623 Glucose in cerebrospinal fluid 17 1 165
B624 Protein in cerebrospinal fluid 17 1 165
HEMOSTASIS SYSTEM
A020 APTT 16 1 097
A025 Prothrombin+INR 27 1 850
A027 Thrombin time 22 1 508
A030 Fibrinogen 16 1 097
A035 Antithrombin III 27 1 850
C139 Protein-C 47 3 221
C142 Protein-S 47 3 221
C515 D-DIMER 60 4 112
C305 Lupus anticoagulant (panel) 53 3 632
A033 Platelet Aggregation 83 5 688
A031 FACTOR VON 170 11 651
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 056
BLOOD DRUG RATES
B142 Folic acid 27 1 850
C710 Determination of ethanol in the blood 60 4 112
T010 Digoxin 79 5 414
T015 Determination of phenobarbital in blood 53 3 632
T020 Phenytoin 53 3 632
T025 Valproic Acid 53 3 632
T030 Carbamazepine 53 3 632
T080 Determination of tacrolimus in blood 59 4 044
T085 Levetiracetam (Keppra) 100 6 854
T097 Therapeutic drug monitoring of Topiramate 24 1 645
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 24 1 645
T100 Determination of the concentration of Amikacin in the blood 43 2 947
T101 The determination of the concentration of Gentamicin in the blood 43 2 947
T102 Determine the concentration of Vancomycin in the blood 43 2 947
NARCOTIC SCREENING
T075 Drug screening in urine 53 3 632
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 673
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 12 816
T088 Amphetamines in urine (quantitative) 28 1 919
T089 Cocaine in urine (quantitative) 28 1 919
T090 Cannabinoids in urine (quantitative) 28 1 919
T091 Barbiturates in urine (quantitative) 25 1 713
T092 Benzodiazepines in urine (quantitative) 28 1 919
T095 Opiates in urine (quantitative) 28 1 919
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 57 3 907
T099 Determination of nicotine and its metabolites in urine for differential diagnosis of active and passive smoking: nicotine, cotinine (GH-MS method) 29 1 988
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 1 850
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 673
B003 Ceruloplasmin 50 3 427
B004 Eosinophil Cationic Protein (ECP) 50 3 427
B007 Cuprum 22 1 508
B100 Glucose 13 891
B101 Standard glucose tolerance test 33 2 262
B102 Vitamin D 107 7 333
B103 Vitamin A 83 5 688
B104 Vitamin B1 83 5 688
B105 Cholesterol 13 891
B107 Pregnancy glucose tolerance test 33 2 262
B108 Vitamin B5 83 5 688
B109 Vitamin B6 83 5 688
B110 Cholesterol-HDL 20 1 371
B112 Vitamin C 83 5 688
B113 Vitamin E 83 5 688
B114 Vitamin K 83 5 688
B115 Cholesterol-LDL 20 1 371
B118 Lactate 25 1 713
B120 Triglycerides 13 891
B122 Angiotensin converting enzyme (ACE) 48 3 290
B125 Bilirubin total 13 891
B130 Bilirubin direct 13 891
B135 Albumin 13 891
B137 Homocysteine 67 4 592
B140 Creatinine 13 891
B144 Zink 38 2 604
B145 Iron 16 1 097
B148 Litium 74 5 072
B150 Iron binding capacity 20 1 371
B155 Total protein 13 891
B160 Protein fractionation (Electrophoresis) 27 1 850
B165 Lipoprotein A 27 1 850
B166 APO-A-1 protein 27 1 850
B167 APO-B protein 27 1 850
B170 Urea 13 891
B175 Uric acid 13 891
B180 Fructosamine 20 1 371
B188 Determination of bile acids in blood 45 3 084
B200 Calcium (total) 16 1 097
B202 Calcium (ionised) 20 1 371
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 10 280
B205 Sodium/Potassium/Chloride 16 1 097
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 1 850
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 1 850
B210 Magnesium 13 891
B215 Phosphate inorganic 13 891
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 9 321
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 221
B219 Study of dialysate for electrolyte composition, pH, glucose 131 8 978
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 221
B300 Amylase 16 1 097
B305 Amylase pancreatic 16 1 097
B310 Lipase 16 1 097
B315 Lactatedehydrogenase (LDH) 13 891
B317 Erythropoietin 47 3 221
B320 Creatine Kinase 13 891
B325 Creatine Kinase MB 16 1 097
B330 Gamma Glutamyle Transferase (GGT) 13 891
B335 Acid phosphatase 16 1 097
B340 Alk. Phosphatase 13 891
B345 Alanine Amino Transferase (ALT) 13 891
B350 Aspartate Amino Transferase (AST) 13 891
B360 Cholinesterase 18 1 234
B362 Determination of C1 esterase inhibitor in blood 45 3 084
B400 C-Reactive Protein 20 1 371
B401 C-reactive protein high sensitivity 30 2 056
B405 Rheumatoid Factor 20 1 371
B410 Anti-streptolysin O titre 20 1 371
B411 Alfa-1-antitrypsin 27 1 850
C415 Ferritin 27 1 850
B430 Haemoglobin A1C 22 1 508
B435 Myoglobin 47 3 221
B440 Transferrin 27 1 850
B445 Troponin I 47 3 221
B450 Troponin T 47 3 221
B451 BNP (brain natriuretic peptide) 87 5 963
B556 The N-terminal peptide NT-proBNP 88 6 031
B604 Alpha-2-Macroglobuline 47 3 221
B610 Haptoglobin 47 3 221
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 8 910
B702 Procalcitonin (quant) 60 4 112
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 221
B025 Microproteinuria 13 891
B132 Urea (random portion) 12 822
B133 Uric acid (random portion) 12 822
B139 The content of Cu (copper) in the urine (a single portion of urine) 14 960
B149 Determination of iodine content in urine - I (iodine) 12 822
B173 Glucose (random portion) 13 891
B182 Alpha Amylase (random portion) 18 1 234
B505 NA+/K+/Cl (random portion) 20 1 371
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 280
B134 Calcium (random portion) 18 1 234
B008 The content of Cu (copper) in the urine (daily) 14 960
B703 Gas chromatography of urine (organic aciduria) 250 17 134
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 234
B141 Creatinine (24h) 18 1 234
B171 Urea (24h) 18 1 234
B176 Uric acid (24h) 18 1 234
B177 Phosphate inorganic (24h) 18 1 234
B178 Magnesium (24) 18 1 234
B179 Glucose (24h) 18 1 234
B183 Total Protein (24h) 18 1 234
B506 Na (24h) 20 1 371
B507 K (24h) 20 1 371
B508 Cl (24h) 20 1 371
B516 Calcium urine test (24h) 22 1 508
B550 Oxalate in urine 40 2 741
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 1 645
B562 Urine protein electrophoresis 40 2 741
B520 Stone chemistry - Profile 79 5 414
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 302
B420 Immunoglobulin M (IgM) 19 1 302
B425 Immunoglobulin G (IgG) 19 1 302
C299 Circulating Immune Complex 22 1 508
C300 IgE total 27 1 850
C285 Interferon sensibility state 293 20 081
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 13 707
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 13 707
C293 Compliment Componenta C3 33 2 262
C294 Compliment Componenta C4 33 2 262
C295 Neutrophilic Bactericidal Activity (HCT test) 27 1 850
C290 Interleukin 6 34 2 330
C291 Interleukin 8 34 2 330
C296 Interleukin 10 34 2 330
C298 Tumor Necrosis Factor 39 2 673
C281 Interleukin 1 Beta 50 3 427
C307 Determination of amyloid - beta (1-42) in blood and in cerebrospinal fluid 83 5 688
B704 Oligoclonal IgG in liquorrhea & serum 120 8 224
Diagnosis Of Auto-Immune Diseases
C023 Cardiolipin antibodies, IgM 50 3 427
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 5 688
C101 Anti-smooth muscle antibodies (ASMA) 50 3 427
C102 Anti-mitochondrial antibodies (AMA) 50 3 427
C167 Determination of аntibodies to nuclear antigens (ANA), IgG, 25 antigens: nucleosomes, dsDNA, histones, Sm, RNP(68kD/A/C), Sm / RNP, SSA / Ro 60kD, SSA / Ro 52kD, SSB, Scl-70, Ku, PM-Scl 100, Mi-2, Jo-1, PL-7, PL-12, SRP, ribosomes, CENP-a / B, GP100, PC100, M2, M2/nPDC and f-actin; quality, with decoding 118 8 087
C168 Determination of аntibodies to liver antigens, IgG, 7 antigens: M2 / nPDC, gp210, sp100, LKM1, LC1, SLA, f-actin; with decoding 49 3 358
C169 Determination of аntibodies for diagnosis of polymyositis/ scleroderma, IgG, 8 antigens: Jo - 1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl-100, Scl-70; quality,  with decoding 76 5 209
C171 Determination of аntibodies to extractable nuclear antigens (ENA screen) and nucleosomes, IgG, 7 antigens: nucleosomes, Sm, Sm/RNP, SSA (Ro), SSB (La), Jo-1, Scl-70; quality,  with decoding 22 1 508
C175 Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 18 1 234
C176 Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 18 1 234
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 084
C203 Scl-70 antibodies 50 3 427
C225 Thyroglobulin antibody 33 2 262
C230 Thyroperoxidase antibody 33 2 262
C231 Auto AB TSH-receptor 53 3 632
C233 Antispermatic Antibodies 67 4 592
C235 AB Insulin IgG 40 2 741
C236 AB insular beta-cells 67 4 592
C240 Antibodies acetylcholine receptor 160 10 966
C242 Antibodies skeletal muscles 70 4 798
C243 Antibodies gangliosides, blot 90 6 168
C244 Myositis antibodies, blot 90 6 168
C245 Anti-neuronal antibodies, blot 110 7 539
C246 Antibodies NMDA receptor 150 10 280
C247 Antibodies Sm 50 3 427
C248 Antibodies gliadine deamidated peptides IgG 45 3 084
C249 Antibodies gliadine deamidated peptides IgA 45 3 084
C250 Antibodies RNP-70 45 3 084
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 309 21 178
C253 Blood test on APG 111 7 607
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 55 3 769
C256 Definition of CD20 in peripheral blood 54 3 701
C257 Typing of CD-34 + cells 60 4 112
C258 Myelogram 131 8 978
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 83 5 688
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 83 5 688
C261 Determination of Tau protein in biological fluids 83 5 688
C262 Determination of glial fibrillar acid protein (GFAP) 107 7 333
C263 Comprehensive study (immunophenotyping) panel for serous discharge: CD45/CD15/CD71/CD40/CD95/CD30/CD3/CD19 300 20 561
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 36 2 467
C500 Nuclear antibody (IF) 47 3 221
C505 Cardiolipin antibody IgG 47 3 221
C506 Cardiolipin antibody IgA 25 1 713
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 309 21 178
C533 Anti-dsDNA 53 3 632
C534 Anti-ssDNA 53 3 632
C535 Phospholipid Antibody IgG 53 3 632
C536 Phospholipid Antibody IgM 53 3 632
C830 Antibodies Prothrombin 40 2 741
C840 Antibodies Gliadin IgA 40 2 741
C841 Anti-Transglutaminase IgG 47 3 221
C842 Anti-Transglutaminase IgA 47 3 221
C845 Antibodies Reticulin 47 3 221
C846 Antibodies Endomysium 47 3 221
C847 Antibodies Platelet 53 3 632
C848 Antibodies Basic Skin Membrane 73 5 003
C849 Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 36 2 467
C850 Antibodies Gliadin IgG 40 2 741
C851 Beta2 – glycoprotein antibodies 50 3 427
C852 Annexin V antibodies 50 3 427
C853 ENA – extractive nuclear antibodies screen 61 4 181
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 427
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 427
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 15 078
A069 Determination of free light chains FLC in blood 55 3 769
A070 Determination of free light chains (FLC) in urine 35 2 399
ONCOLOGICAL TESTS
C405 PSA total 29 1 988
C410 PSA free 29 1 988
C420 AFP 29 1 988
C425 CEA 29 1 988
C430 CA 125 38 2 604
C435 CA 19-9 29 1 988
C440 CA 15-3 29 1 988
C442 CA 72 - 4 40 2 741
C443 Neuron-Specific Enolase (NSE) 60 4 112
C445 B2 microglobulin 33 2 262
C820 Cyfra-21-1 40 2 741
C822 Squamous Cell Carcinoma (SCC) 39 2 673
C821 UBC (Bladder Cancer Antigen) in urine 39 2 673
C823 HE4 40 2 741
C824 Chromogranin A 56 3 838
SEROLOGY
Syphilis Diagnosis
S000 Determination of anti-cardiolipin antibodies by microreaction precipitation (RPR) (Diagnosis of syphilis) 27 1 850
S001 Determination of antibodies to Treponema pallidum (total) 27 1 850
S002 Determination of total antibodies to Treponema pallidum (quantitative) 30 2 056
S010 Determination of antibodies to Treponema pallidum by indirect hemagglutination(TPHA) 33 2 262
S011 Detection of antibodies to Treponema pallidum by the RIBT method 36 2 467
S012 Detection of antibodies to Treponema pallidum by the RIF method 21 1 439
S091 Determination of anti-Treponema pallidum IgG immunoblot 103 7 059
S092 Determination of anti-Treponema pallidum IgM immunoblot 103 7 059
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 262
A055 Antierythrocytic antibodies (screening) 40 2 741
A056 Direct Cumbs test 33 2 262
A061 Detecting Kell antigen sistem 33 2 262
A064 Phenotyping Rh and Kell 35 2 399
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 221
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 414
C004 Anti-HAV total 40 2 741
C006 Anti-HAV IgM 47 3 221
C007 Hepatitis D Virus HDV antibodies, total 28 1 919
C008 HBsAg 27 1 850
C010 HBeAg 47 3 221
C011 HDV antibodies, IgM 28 1 919
C012 Anti-HBc total 40 2 741
C013 HEV antibodies, IgG 28 1 919
C014 Anti-HBc IgM 47 3 221
C015 HEV antibodies, IgM 28 1 919
C016 Anti-Hbe 47 3 221
C018 Anti-HBs quant. 47 3 221
C020 Anti-HCV IgG 40 2 741
C021 Anti-HCV IgM 44 3 016
C026 Anti-CMV IgG 29 1 988
C028 Anti-CMV IgM 33 2 262
C030 Anti-Rubella IgG 29 1 988
C031 Anti-Parvovirus B19 IgG 40 2 741
C032 Anti Rubella IgM 33 2 262
C033 Anti-Parvovirus B19 IgM 40 2 741
C034 Anti Mumps IgG 53 3 632
C036 Anti Mumps IgM 53 3 632
C038 Anti Measles IgG 53 3 632
C040 Anti Measles IgM 53 3 632
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 221
C044 Anti-HSV 1 IgG 47 3 221
C046 Anti-HSV 1 IgM 53 3 632
C048 Anti-HSV 2 IgG 47 3 221
C050 Anti-HSV 2 IgM 53 3 632
C052 Anti-Varicella Zoster IgG 53 3 632
C054 Anti Varicella Zoster IgM 53 3 632
C058 Anti-EBV-VCA IgG 53 3 632
C060 Anti-EBV-VCA IgM 53 3 632
C094 IgG Respiratory syncytial virus 35 2 399
C096 IgM Respiratory syncytial virus 35 2 399
C152 IgG Dengue virus 25 1 713
C153 IgM Dengue virus 25 1 713
C154 Antibodies to Clostridium tetani (quantitative) 35 2 399
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 3 769
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 3 769
C450 Adenovirus infection 67 4 592
C856 Anti- encephalitis IgG 55 3 769
C857 Anti- encephalitis IgM 55 3 769
S200 Cytomegalovirus (CMV) IgG Avidity 53 3 632
S210 Rubella IgG Avidity 38 2 604
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 221
C064 Helicobacter pylori antibody blot 80 5 483
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 221
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 4 592
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 4 592
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 4 592
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 8 910
C090 Borrelia burgdorf. IgG (qual) 67 4 592
C091 Borrelia burgdorf. IgM (qual) 67 4 592
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 713
C165 Serological diagnosis of borreliosis (immunochip) in blood 14 960
C177 Determination of urease activity Helicobacter pylori, 13C (urease respiratory test) 36 2 467
C519 Anti IgG Legionella pneumophila (qual.) 89 6 100
C522 Anti IgM Legionella pneumophila (qual.) 89 6 100
C645 Brucella IgG 67 4 592
C647 Brucella IgM 67 4 592
D070 Chlamydia pneumoniae IgA 53 3 632
D071 Chlamydia pneumoniae IgG 53 3 632
D072 Anti IgM Chlamydia pneumoniae 53 3 632
D073 Chlamydia psittaci IgG (qual) 67 4 592
D074 Chlamydia psittaci IgM (qual) 67 4 592
D077 Chlamydia psittaci IgA (qual) 67 4 592
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 028
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 685
D110 Mycoplasma pneumoniae IgA (quant) 40 2 741
D115 Mycoplasma pneumoniae IgG (qual) 40 2 741
D120 Mycoplasma pneumoniae IgM (qual) 40 2 741
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 056
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 056
D322 AB Shigella flexneri (total) 60 4 112
D323 AB Shigella sonnei (total) 60 4 112
S070 Ureaplasma urealiticum IgA 67 4 592
S075 Ureaplasma urealiticum IgG 67 4 592
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 508
S232 Anti-Salmonella Typhi Vi-antigen 22 1 508
S233 Anti-Corinebacterium Diphtheriae 22 1 508
C053 Helicobacter pylori IgM 44 3 016
C063 Helicobacter pylori IgA 44 3 016
C103 Immunoblot Borrelia burgdorferi IgG 60 4 112
C104 Immunoblot Borrelia burgdorferi IgM 60 4 112
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 685
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 685
S007 Determination of antigen Legionella pneumophila in urine (express test) 25 1 713
S008 Determination of streptococcus pneumoniae antigen 25 1 713
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 4 592
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 4 592
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 4 592
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 4 592
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 221
D312 Lamblia intestinalis IgM 47 3 221
D315 Antibody to ascaris antigen IgG (qual.) 40 2 741
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 4 592
D325 Antibodies to Opistorchis IgG (quantitatives) 67 4 592
D326 Antibodies to Toxocara IgG (quantitative) 67 4 592
D327 Antibodies to Trichinella lgG (quantitative) 67 4 592
D328 Antibodies Ascaris IgG (quantitative) 67 4 592
D329 The blood test for trichinosis (rostirolla) 19 1 302
D330 The blood test for toxocariasis (rostirolla) 19 1 302
D331 Blood test for clonorchiasis (IgG) by ELISA 24 1 645
D332 The blood test for anisakis (IgG) by ELISA 24 1 645
D333 Determination of antibodies class G (IgG) to the causative agent of leishmaniasis (IgG) in the blood by ELISA 27 1 850
C049 Strongyloides stercoralis antibodies 44 3 016
C051 Taenia solium antibodies, IgG 44 3 016
C055 Fasciola hepatica antibodies, IgG 44 3 016
C057 Schistosoma mansoni antibodies, IgG 44 3 016
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 1 988
C024 Toxoplasma gondii IgM (qual) 38 2 604
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 016
S220 Toxoplasma IgG Avidity 46 3 153
C625 Entamoeba sp AB (total) 80 5 483
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 1 850
C205 Total T3 27 1 850
C210 Free T3 27 1 850
C215 Total T4 27 1 850
C220 Free T4 27 1 850
C222 Calcitonin 40 2 741
C223 Thyroglobulin 40 2 741
C224 Thyroid Binding Globulin (TBG) 40 2 741
Reproduction
B151 Dihydrotestosterone 53 3 632
C100 Follicle stimulating hormone 29 1 988
C105 Luteinising hormone 29 1 988
C106 Globulin, linking sex hormones (SHBG) 47 3 221
C110 Testosterone 29 1 988
C115 Prolactin 29 1 988
C117 Testosterone Free 47 3 221
C125 Estradiol 29 1 988
C126 Estriol Free 38 2 604
C130 Progesterone 29 1 988
C141 Inhibin В 93 6 374
C143 AMH (Anti-Mullerian Hormone) 93 6 374
C159 Definition of Macroprolactin 10 685
C227 Androstenedione 60 4 112
C400 Beta HCG 33 2 262
C404 Androstanediol glucuronide 50 3 427
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 80 5 483
IVF83 Evaluation of ovarian reserve 197.6 13 543
Follicle stimulating hormone
Fertility specialist consultation including ultrasound examination
AMH (Anti-Mullerian Hormone)
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 604
B531 17-alpha-Hydroxy-Progesteron 29 1 988
B536 Free cortisol (urine, 24h) 40 2 741
C120 Cortisol 29 1 988
C135 Dehydroepiandrosterone 33 2 262
C140 Adrenocorticotrophin 53 3 632
C178 Comprehensive blood test for unsaturated fatty acids of the Omega-3 family: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), gas chromatography - mass spectrometry (GC-MS) method 39 2 673
C179 Determination of the Omega-3 index (assessment of the risk of sudden cardiac death, myocardial infarction and other cardiovascular diseases), gas chromatography - mass spectrometry (GC-MS) method) 46 3 153
C180 A comprehensive blood test for unsaturated fatty acids of the Omega-6 family: linoleic, gamma-linolenic, digamogamma-linolenic, arachidonic, eicosadienic, docosadienic, docosatetraenoic acids, gas chromatography - mass spectrometry (GC-MS) method 39 2 673
C181 Comprehensive blood test for unsaturated fatty acids of the Omega-3 and Omega-6 family, gas chromatography - mass spectrometry (GC-MS) method 78 5 346
C452 Determination of cortisol in saliva 25 1 713
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 62 4 249
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 117 8 019
C462 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 114 7 813
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 8 704
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 8 704
G123 Mucoviscidosis CFTR 300 20 561
G423 A study of the fragmentation of sperm DNA by the method of SCD 283 19 396
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 283 19 396
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 153
C132 Parathormone 47 3 221
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 016
C147 Bone resorption - deoxypiridinolin 67 4 592
C182 Study of the level of N-terminal propeptide of type 1 procollagen (P1NP) in the blood 18 1 234
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 5 483
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 153
B527 Somatomedin-C 46 3 153
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 2 741
B533 Proinsulin 60 4 112
B534 С-peptide 47 3 221
B539 Antibody-GAD 53 3 632
C108 Leptin 53 3 632
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 140
C158 Melatonin 51 3 495
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 3 632
BIOGENIC AMINES
C700 Serotonin 60 4 112
C800 Histamine 60 4 112
C900 Tryptase 75 5 140
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C157 Catecholamines and serotonin 38 2 604
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 112
C172 Determination of metabolites of biogenic amines: homovanilic acid (GVK), vanillin-mandelic acid (IUD) in urine, 24 h. 22 1 508
C173 Definition of free fractions of a metanefrin and normetanefrin (nekonyyugirovanny with SO4) in urine, 24 h. 24 1 645
C174 Determination of total epinephrine and norepinephrine metabolites: metanephrine, normetanephrine (free and conjugated with SO4) in urine, 24 h. 24 1 645
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 371
C311 Specific IgE for Allergen Mix / qual 33 2 262
C312 Single recombinant allergic components, inhalation (One name) 20 1 371
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 754
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 371
C315 General Inhalation Allergy Panel 160 10 966
C331 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: t215 birch wart/betula verrucosa, recombinant allergocomponent (rBet vl/PR-10 protein) 43 2 947
C332 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: g213 timothy meadow/phleum pratense, recombinant allergocomponent(rPhl pl, rPhl p5) 43 2 947
C333 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: w230 ambrosia elatior, a. artemisiifolia, ative allergosorbent(nAmb al) 43 2 947
C334 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: w231 artemisia vulgaris,native allergosorbent(nArt vl) 43 2 947
C340 General Food Panel 160 10 966
C350 Allergy Panel/ primary screening 120 8 224
C351 Allergy pediatric panel, IgE (20 allergens) 156 10 692
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 1 919
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 508
C362 Antibacterial drugs (antibiotics) (specific IgE), one name. 10 685
C363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 10 685
C364 Local anesthetics (specific IgE). One name. 10 685
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 21 1 439
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 20 1 371
C367 Local anesthetics (specific IgG). One name. 20 1 371
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 1 850
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 508
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 427 29 265
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 822
C382 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel house dust, mixed hx2: h2 Hollister-Stier Labs, d1 dermatophagoides pteronyssinus, d2 dermatophagoides farinae, i6 crotonbug (blatella germanica) 14 960
C383 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx1: m1 Penicillium notatum (P. chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m6 Alternaria alternata 14 960
C384 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx2: m1 Penicillium notatum (P.chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m5 Candida albicans, m6 Alternaria tenuis, m8 Setomelanomma rostrata 14 960
C385 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets (epithelium), mixed ex1: e1 cat (dander), e5 dog (dander), e3 horse (dander), e4 cow (dander) 15 1 028
C386 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets, mixed ex2: e1 cat (dander), e5 dog (dander), e6 guinea pig (epithelium), e87 rat (epithelium, serum proteins and urine), е88 mouse (epithelium, serum proteins and urine) 19 1 302
C387 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel rodents, mixed ex70: e6 guinea pig (epithelium), e82 rabbit (epithelium), e84 hamster (epithelium), e87 rat (epithelium, serum and urine proteins), e88 mouse (epithelium, urine and serum proteins) 14 960
C388 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel bird feathers, mixed ex72: e78 budgerigar (feather), e201 canary (feather), e196 parakeet (feather), e213 parrot (feather), e214 wren (feather) 16 1 097
C389 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx5: t2 alder, t4 hazel, t8 elm, t12 white willow, t14 poplar 16 1 097
C391 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx6: t1 maple, t3 birch, t7 white oak, t5 Beech, t10 walnut 16 1 097
C392 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx9: t2 alder gray (alnus incana); t3 white birch (betula verrucosa); t4 common hazell (corylus avellana); t7 white oak, t12 white willow 14 960
C393 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pollen early-flowering meadow grasses, mixed gx1: g3 cocksfoot (dactylis glomerata), g4 meadow fescue (festuca elatior), g5 perennial ryegrass (chaff); g6 timothy grass (phleum pratense), g8 kentucky bluegrass 16 1 097
C394 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx1: w1 ragweed, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w11 ash pan (saltwort) 16 1 097
C395 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx2: w2 ambrosia golometelchataya, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w15 quinoa 16 1 097
C396 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx3: w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w12 goldenrod, w20 stinging nettle 19 1 302
C397 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel infant formula, mixed fx5: f1 egg white, f2 cow's milk, f3 cod, f4 wheat flour, f13 peanuts, f14 soybeans 16 1 097
C398 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel seafood, mixed fx2: f3 atlantic cod, f24 northern shrimp, f37 blue mussel, f40 tuna, f41 salmon 16 1 097
C399 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fish mixed fx74: f3 atlantic cod, f205 herring, f206 mackerel, f254 flounder 16 1 097
C470 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel meat mixed fx74: f26 pork, f27 beef, f83 chicken 19 1 302
C471 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel flour and cereal sesame, mixed fx3: f4 wheat, f7 oat, f8 maize, f10 sesame seed, f11 buckwheat 16 1 097
C472 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel lour, cereal, mixed FX20: f4 wheat, f5 rye, f6 barley, f9 rice 16 1 097
C473 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables and legumes, mixed fx13: f12 pea, f15 white beans, f31 carrot, f35 potato 16 1 097
C474 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables, mixed fx14: f25 tomato, f214 spinach; f216 white cabbage, f218 paprika and sweet pepper 16 1 097
C475 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel nuts, mixed fx1: f13 peanut, f17 hazel nut, f18 brazil nut, f20 almond, f36 coconut 16 1 097
C476 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel citrus and fruit, mixed fx15: f33 orange, f49 apple, f92 banana, f95 peach 16 1 097
C477 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fruits and melons, mixed fx21: f84 kiwi fruit, f87 melon, f92 banana, f95 peach, f210 peneaple 16 1 097
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 21 931
C463 Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 309 21 178
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 399
P019 DNA Salmonella species in stool 25 1 713
P021 Colibacillosis 40 2 741
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 673
P009 Mycoplasma pneumoniae DNA 22 1 508
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 4 592
P030 HSV I & II 20 1 371
P031 Human Papilloma virus 31, 33 20 1 371
P032 Human Papilloma virus 6,11 20 1 371
P033 Herpes Simplex virus II 20 1 371
P035 H. Papilloma virus 16, 18 20 1 371
P042 Varicella-Zoster virus 20 1 371
P070 Cytomegalovirus 20 1 371
P080 Epstein-Barr virus 20 1 371
P105 Human Papilloma virus sp. 20 1 371
P004 Rubella Virus in blood (qual) 40 2 741
P120 Herpes Simplex virus VI (qual) 18 1 234
P125 Enterovirus (RNA) 33 2 262
P126 DNA Pneumocystis carinni 17 1 165
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 427
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 73 5 003
P129 RNA Zika virus (blood) 80 5 483
P130 RNA Zika virus (ejaculate) 33 2 262
P131 RNA Zika virus (Amniotic fluid) 33 2 262
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 4 798
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 32 2 193
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 028
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 58 3 975
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 371
P036 M.Tuberculosis-M.bovis 22 1 508
P038 Streptococcus group A (pyogenes) 22 1 508
P065 Listeria monocytogenes 22 1 508
P075 Pseudomonas aeruginosa 22 1 508
P085 Bordetella pertussis (PCR) 22 1 508
P095 Helicobacter pylori 38 2 604
P097 Haemophilus influenzae 20 1 371
P098 Streptococcus pneumoniae 20 1 371
P099 DNA Treponema pallidum 20 1 371
P103 Legionella pneumophila 10 685
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 685
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 371
P005 Mycoplasma hominis 20 1 371
P006 Mycoplasma genitalium 20 1 371
P015 Ureaplasma species 20 1 371
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 371
P020 Neisseria gonorrhoeae 20 1 371
P025 Gardnerella vaginalis 20 1 371
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 371
P012 Toxoplasma gondii 22 1 508
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 508
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 3 632
P045 Hepatitis B qualitive (HBV-DNA) 33 2 262
P050 Hepatitis C quant. (HCV-RNA) 253 17 340
P055 Hepatitis C qualitive (HCV-RNA) 38 2 604
P060 HCV-RNA (genotype determination) 40 2 741
P061 Hepatite G qual. (HGV-RNA) 40 2 741
P062 Hepatite D qual. (HDV-RNA) 40 2 741
P008 Hepatitis A Virus RNA (HAV-RNA) 40 2 741
P063 Genotype of hepatitis B 35 2 399
P101 Hepatitis C Virus RNA (ultrasensitive method) 78 5 346
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 193 13 227
P132 Definition of HIV RNA (type 1) (quantitative) 109 7 470
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 10 692
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 157 10 760
G122 SNP identification in human IL28B gene 60 4 112
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 15 763
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 14 393
G136 FISH panel Myelodysplastic syndrome (6 probes) 261 17 888
G137 CYP2D6 analysis polymorphisms 140 9 595
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 29 470
G139 Familial adenomatous polyposis , polypoid colon cancer 430 29 470
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 594 40 710
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 56 199
G156 BRCA1 и BRCA2 polymorphism 225 15 421
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 68 536
G159 Sequence SCN1 A (Dravet syndrome) 825 56 542
G160 Fragile X mental retardation syndrome (methylation) 190 13 022
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 18 025
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 116 511
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 143 9 801
G165 Paternity test 480 32 897
G167 Non Invasive Fetal Rhesus factor Determination 188 12 885
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 10 280
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 854 58 530
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 854 58 530
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 71 277
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 47 975
G197 Calreticulin (CALR) 81 5 551
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 593 40 642
G216 Genetic predisposition to breast cancer and ovarian cancer 127 8 704
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 239 16 380
G232 Stomach cancer 464 31 801
G233 Pancreas cancer 100 6 854
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 635 43 520
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 211 14 461
G254 Sensorineural hearing loss 43 2 947
G255 Muscle atrophy 71 4 866
G256 Long QT syndrome 99 6 785
G264 Lactose intolerance 71 4 866
G265 Gilbert's syndrome - a confirmatory test 43 2 947
G268 Psoriasis 71 4 866
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 43 2 947
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 195 13 364
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 195 13 364
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 195 13 364
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 225 15 421
G289 Activity GATA2 gene for prostate cancer (blood test) 195 13 364
G290 Activity IGF1 gene for prostate cancer (blood test) 195 13 364
G291 Activity IGF2 gene for prostate cancer (blood test) 195 13 364
G292 Activity IL4 gene for prostate cancer (blood test) 195 13 364
G293 Activity IL10 gene for prostate cancer (blood test) 195 13 364
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 311 21 315
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 124 8 498
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 641 43 931
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 1000 68 536
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 546 37 421
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1550 106 230
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2660 182 305
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4430 303 614
G308 PGD ​​monogenic diseases 1 category of complexity 1330 91 153
G309 PGD ​​monogenic diseases 2 category of complexity 2215 151 807
G310 PGD ​​monogenic diseases 2 category of complexity 3325 227 882
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 450 30 841
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 550 37 695
G315 Full sequencing of exome 2105 144 268
G316 Panel "Diseases of conjunctive tissue" 676 46 330
G317 Panel "Patrimony of cardiopathy" 676 46 330
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 688 47 153
G319 Search for mutations in the gene CAV 3 143 9 801
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 641 43 931
G321 Panel "Hypertension" 83 5 688
G322 Panel "Hypertension and selection of pharmaceutical drugs" 145 9 938
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 380 26 044
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 190 13 022
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 593 40 642
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 262 17 956
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 178 12 199
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 178 12 199
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 855 58 598
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 617 42 287
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 252 17 271
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 238 16 312
G333 Myriad MyRisk 3810 261 121
G334 Myriad BRCA1 Analysis 2405 164 829
G335 Myriad BRCA2 Analysis 2495 170 997
G336 Myriad COLARIS PLUS 3290 225 483
G337 Myriad MLH1 Analysis 2055 140 841
G338 Myriad MSH2 Analysis 1786 122 405
G339 Myriad MSH6 Analysis 2185 149 751
G340 Myriad PMS2 Analysis 2051 140 567
G341 Myriad MYH Sequence Analysis 1965 134 673
G342 Myriad Comprehensive MELARIS 1667 114 249
G343 Myriad Comprehensive PANEXIA 3290 225 483
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 80 5 483
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 155 10 623
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 67 4 592
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 193 13 227
G355 Myriad BRAC Analysis 2850 195 327
G356 Myriad Single-Site BRACAnalysis 1184 81 146
G357 Myriad MultiSite 3 BRACAnalysis 1387 95 059
G358 Myriad Reflex BRACAnalysis 2582 176 959
G359 Myriad BRACAnalysis Rearrangement Test (BART) 1476 101 159
G360 Myriad Single-Site COLARIS 1184 81 146
G361 Myriad COLARIS AP PLUS 2850 195 327
G362 Myriad Single-Site COLARIS AP 1184 81 146
G363 Myriad MYH Mutation Panel 1100 75 389
G364 Myriad Reflex MYH Sequence Analysis 1680 115 140
G365 Myriad Single-Site MELARIS 1184 81 146
G366 Myriad Single-Site PANEXIA 1184 81 146
G367 Myriad PALB2 Analysis 2110 144 611
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 71 277
G376 Molecular karyotyping abortion material OPTIMA 333 22 822
G377 Chromosomal micrometrical analysis of abortive material Standard 558 38 243
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 642 44 000
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 475 32 555
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 475 32 555
G388 The allocation and storage of DNA 24 1 645
G389 Panel "Disorders of hemostasis" 30 tokens 215 14 735
G391 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy at 21 chromosome (Down syndrome) + sex determination 330 22 617
G392 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + definition of sex (for pregnancy two fruits) 570 39 065
G393 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + numerical disorders of sex chromosomes and sex determination 570 39 065
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 157 10 760
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 145 9 938
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 262 17 956
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 380 26 044
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 380 26 044
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 298 20 424
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 392 26 866
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 333 22 822
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 238 16 312
G425 The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 235 16 106
G469 Determination of polymorphisms associated with lactose metabolism 24 1 645
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 13 707
TISSUE TYPING
G020 HLA TYPING B27 200 13 707
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 5 483
M003 Bacterioscopic stained smear 30 2 056
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 221
M006 Determination of microbiocenosis by chromatography-mass spectrometry (MSMM) 119 8 156
M010 Mycology & Fungigram 90 6 168
M100 Disbacteriosis 107 7 333
M130 Corynebacterium diphtheriae (BL) 29 1 988
M135 Enteropathogenic bacteria (BD) 35 2 399
M170 Staphylococcus aureus 52 3 564
M350 Yersinia enterocolitica (stool culture) 52 3 564
M560 Listeria (with resistance) 38 2 604
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 57 3 907
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 57 3 907
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 18 1 234
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 371
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 18 1 234
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 17 1 165
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 15 1 028
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 10 280
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 6 854
M151 Microbiology of blood by fungi (double reseeding) 130 8 910
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 5 483
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 8 910
M156 Mycology of sputum by fungi, microscopy and culture 80 5 483
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 8 910
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 7 539
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 224
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 5 483
M136 Mycology of conjunctiva discharge by fungi (culture) 100 6 854
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 224
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 4 798
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 5 483
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 168
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 7 882
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 5 483
COMPLEX LABORATORY TESTS
K001 Cardiorisk 440 30 156
Prothrombin+INR
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Sodium/Potassium/Chloride
Lactatedehydrogenase (LDH)
Creatine Kinase
Creatine Kinase MB
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
C-Reactive Protein
Myoglobin
Troponin I
BNP (brain natriuretic peptide)
K002 Lipidic screening 200 13 707
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Lipoprotein A
APO-A-1 protein
APO-B protein
K003 Liver Function 120 8 224
Albumin
Total protein
Bilirubin total
Bilirubin direct
Lactatedehydrogenase (LDH)
Creatine Kinase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K004 TORCH 379 25 975
Anti-CMV IgG
Anti-CMV IgM
Anti-Rubella IgG
Anti Rubella IgM
Anti-HSV 1 IgG
Anti-HSV 1 IgM
Anti-HSV 2 IgG
Anti-HSV 2 IgM
Toxoplasma gondii IgG (quant)
Toxoplasma gondii IgM (qual)
K005 Thyroid gland 240 16 449
Thyroglobulin antibody
Thyroperoxidase antibody
Thyroid stimulating hormone
Total T3
Free T3
Total T4
Free T4
Thyroglobulin
K006 Anemia 219 15 009
Cell Blood Count+differential
Sedimentation rate
Reticulocytes
Folic acid
Vitamin B12
Iron
Iron binding capacity
Transferrin
Ferritin
K007 Osteoporosis 201 13 776
Calcium (total)
Phosphate inorganic
Alk. Phosphatase
Osteocalcin
Parathormone
Bone resorption - deoxypiridinolin
K008 Biochemical screening 160 10 966
Cell Blood Count+differential
Sedimentation rate
Creatinine
Total protein
Urea
Glucose
Cholesterol
Bilirubin total
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.1 Complex "Chemotherapy. Biochemical screening" №1 90 6 168
Cell Blood Count+differential
Standard urine test
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.2 Complex "Chemotherapy. Biochemical screening" №2 85 5 826
Cell Blood Count+differential
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K011 Fibro Test/ Acti Test 300 20 561
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 26 044
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
K013 LifeSpan Lab Pre-Check Male 219 15 009
Vitamin D
Magnesium
Testosterone
Dehydroepiandrosterone
Insulin
K014 LifeSpan Lab Pre-Check Female 219 15 009
Vitamin D
Magnesium
Testosterone
Estradiol
Progesterone
Insulin
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 100
G100 TIMP-2 - study of lung cancer invasiveness 89 6 100
G008 TGF B - study of prostate cancer invasiveness 89 6 100
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 427
G010 BRCA1 4153delA 50 3 427
G011 BRCA1 185delAG 50 3 427
G012 BRCA1 C61>G 50 3 427
G014 BRCA1 2080delAA 50 3 427
G015 BRCA2 6174delT 50 3 427
G016 BRCA2 9318 delAAAA 50 3 427
G021 CHEK2 ivs2+1G>A 50 3 427
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 88 6 031
G053 BCR-ABL p190 t(9;22) 88 6 031
G054 BCR-ABL p230 t(9;22) 88 6 031
MUTATIONS, CHIMERISM
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 155 10 623
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 100
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 62 4 249
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 60 4 112
G107 Deletion in 12 exon gene Jak-2 kinase 86 5 894
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 111 7 607
G152 Germinal mutation 62 4 249
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 110 7 539
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 785 53 801
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 95 6 511
G374 Prenatal DNA diagnosis (Wilson's Disease) 193 13 227
G381 PMP22(1.5-MB Del) 29 1 988
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 29 1 988
G383 PMP22 (1-BP INS, 325G; rs80338763) 29 1 988
G384 PMP22 (Ala67Thr: rs104894623) 29 1 988
G385 PMP22 (EX2-3DEL; nsv1197510) 29 1 988
G386 PDGFRα, FIP1L1 - markers of eosinophilia 88 6 031
G387 Genotyping on the RH factor, including heterozygous carrier 126 8 636
G390 Panel "Phacomatosis and hereditary cancer" 678 46 467
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 136 9 321
G408 Analysis of carriers of spinal ametropia 155 10 623
G409 Screening for hereditary diseases (2500 genes) 676 46 330
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 65 4 455
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 223 15 283
G412 Search 9 most frequent mutations in the CYP210HB gene 155 10 623
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 183 12 542
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 83 5 688
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 75 938
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 83 477
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 104 723
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 112 330
G420 Confirmation of previously found mutation sequencing by Sanger 120 8 224
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 119 8 156
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 715 49 003
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 95 6 511
G432 Neurodegenerative diseases - APOE gene genotyping 60 4 112
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 119 8 156
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 285 19 533
G435 BAS - screening of the coding region of the SOD1 gene 285 19 533
G442 The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 178 12 199
G443 Complex genetic research: hereditary diseases of the gastrointestinal tract 676 46 330
G444 Search for mutations in 63 genes responsible for SPG in spastic paraplegia of Strumpel 688 47 153
G445 Full genome sequencing GenomeUNI 1840 126 106
G446 Research on the genome FERTY 1440 98 692
G447 Search for mutations in the FKTN gene (Muscular dystrophy of the Fukuyama type) 428 29 333
G448 Finding a relative’s identified mutations in this family (Muscular dystrophy of the Fukuyama type) 95 6 511
G449 Search for frequent mutations in CAPN3, FKRP, ANO5, SGCA genes (muscular dystrophy of the lumbar) 110 7 539
G450 Search for mutations in genes CAPN3, DMD, EMD, SGCG, SGCA, SGCB,SGCD, TCAP, FKRP, POMT1, ANO5, FKTN, ISPD, LMNA, CAV3 (muscular dystrophy of the lumbar) 690 47 290
G451 Search for mutations in the FKRP gene (muscular dystrophy of the lumbar) 136 9 321
G452 Search for mutations in the SGCA gene (muscular dystrophy of the lumbar) 214 14 667
G453 Search for mutations in the SGCB gene (muscular dystrophy of the lumbar) 214 14 667
G454 Search revealed in this family mutations in a relative (muscular dystrophy of the lumbar) 95 6 511
G455 Prenatal DNA diagnosis (muscular dystrophy of the lumbar) 193 13 227
G456 Finding mutations in the EMD gene (Emery-Dreyfus muscular dystrophy) 136 9 321
G457 Finding mutations in the LMNA (Emery-Dreyfus muscular dystrophy) 356 24 399
G458 Finding mutations in the FHL1 gene (Emery-Dreyfus muscular dystrophy) 285 19 533
G459 Search revealed in this family mutation in a relative (Emery-Dreyfus muscular dystrophy) 67 4 592
G460 Prenatal DNA diagnosis Emery-Dreyfus muscular dystrophy 193 13 227
G461 Search for deletions and duplications in the DMD gene in boys (Duchenne/Becker muscular dystrophy) 214 14 667
G462 Search deletions and duplications in the patient's relatives in the female line (Duchenne/Becker muscular dystrophy) 250 17 134
G463 Search for point mutations in the DMD gene (Duchenne/Becker muscular dystrophy) 688 47 153
G464 Search for a point mutation identified in this family from a relative (Duchenne/Becker muscular dystrophy) 67 4 592
G465 Prenatal DNA diagnosis (Duchenne/Becker muscular dystrophy) 193 13 227
G466 Determination of mutations in MYD88 GENE (L265P) (associated with primary resistance to ibrutinib) 137 9 389
G467 Determination of B-cell clonal rearrangement of heavy chain IG (IgH) genes 149 10 212
G468 Chromosomal micromatrix analysis advanced 712 48 797
G470 Hypertrophic cardiomyopathy (expanded panel of 118 genes) 2407 164 966
G471 Long QT syndrome (32 gene expanded panel) 2075 142 212
G472 Diseases of the conduction system of the heart (44 genes) 2075 142 212
G473 Arrhythmogenic cardiomyopathy (12 gene) 1245 85 327
G474 Dyslipidemia, early atherosclerosis (total panel 104 genes) 1643 112 604
G475 Molecular genetic study (search) of exon deletions and frequent inversions in the F8 gene in hemophilia A 155 10 623
G476 Molecular genetic study (search) of mutations in the F9 gene in hemophilia B 250 17 134
G477 Molecular genetic research (search) of mutations in genes F8, F9, VWF (Hemophilia) 690 47 290
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
EXPRESS DIAGNOSTICS
E002 General Biochemistry express screening 122 8 361
C-Reactive Protein
Albumin
Bilirubin total
Alanine Amino Transferase
Asparate Amino Transferase
Gamma Glutamyle Transferase
Alk. Phosphatase
Amylase
Glucose
Urea
Creatinine
Calcium
Uric acid
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 14 598
M206 Histological examination of the placenta 300 20 561
M207 Complex histological and immunohistochemical study of endometrial cancer 400 27 414
H250 Histology of tumor surgical samples 389 26 660
H299 Intraoperative (urgent) histology and cytology 200 13 707
H270 Histology of breast wide local excision (lumpectomy) specimen 389 26 660
H271 Histology of mastectomy speciment 367 25 153
H272 Histology of sentinel lymph node with IHC if necessary 280 19 190
H273 Histology of lymph node dissection speciment 213 14 598
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 8 704
M202 Hystology with supplementary staining for helicobacter pylori 227 15 558
M203 Multiple histology 3 samples and more 344 23 576
H205 Histology of scrapings of the uterus 213 14 598
H206 Histology of the mammary gland punctates 213 14 598
H207 Histology of liver bioptates 213 14 598
H208 Histology of CT-guideline needle biopsy 397 27 209
H209 Histology of skin (PUNCH-biopsy) 213 14 598
H210 Histology of skin tumors 198 13 570
H211 Histology of bone marrow patho bioptate 280 19 190
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 10 692
H231 Consultation with the making of histology specimens with paraffin blocks 224 15 352
H232 Consultation with the making of specimens and immunohistochemistry 358 24 536
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe (telepathology) 524 35 913
H234 Consultation histological slides by a qualified pathologist USA, University of Southern California 445 30 498
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 305
H274 Consultation of histology and cytology slides by the head of pathology lab 215 14 735
H275 Consultation of histology specimens of specialist-pathologist from Europe, Helios Clinic (telepathology) 498 34 131
CYTOLOGY
M300 Citology / 1 lame 75 5 140
M301 Cytologic cervical smear (Pap Smear) 94 6 442
M302 Integrated cytology PAP-test and HPV typing 117 8 019
M303 Complex immunocytochemical study of thyroid neoplasms 450 30 841
M304 Complex cytological and immunocytochemical examination of pleural fluid 110 7 539
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 346
Z303 Cytology of the mammary gland 75 5 140
Z304 Cytology of the thyroid gland punctate 117 8 019
Z305 Cytology of liquid 78 5 346
Z306 Cytology of endoscopic material 56 3 838
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 346
Z308 Cytology of surgical samples 78 5 346
Z309 Cytology of the lymph nodes punctate 94 6 442
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 346
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 22 1 508
Z315 Urgent cytology performed during endoscopic procedures (preparation and evaluation of cytologic drug clinical laboratory diagnostic by cytologist) 150 10 280
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 19 053
I002 Immunohistochemical differential diagnosis of tumors 389 26 660
I003 Immunohistochemistry of one marker panel differential diagnosis 213 14 598
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 31 321
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 256 17 545
I006 Immunocytochemistry 256 17 545
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 15 078
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 17 545
I009 Immunohistochemical study of PDL-1 gene expression 275 18 847
I010 Immunohistochemical study of up to 5 antibodies 229 15 695
I011 Immunohistochemical study from 5 to 10 antibodies 361 24 741
I012 Immunohistochemical study from 10 to 20 antibodies 541 37 078
I013 Complex histological and immunohistochemical study of biopsies of the prostate 450 30 841
GENETIC ANALYSIS
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 27 414
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 346 23 713
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 340 23 302
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 348 23 850
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 348 23 850
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 348 23 850
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 347 23 782
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 348 23 850
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 348 23 850
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 19 670
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 19 670
G202 EGFR gene amplification (sensitivity to cetuximab) 259 17 751
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 12 199
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 16 174
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 7 676
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 348 23 850
G207 Determination of the methylation status of the promoter body and MGMT gene 177 12 131
G368 Tissue test in ovarian cancer treatment 3213 220 206
G369 Agression degree in prostate cancer 4310 295 389
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 4310 295 389
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 166 953
G404 Express research of additional biomarkers 242 16 586
G405 Biological profiling of tumor (Caris Target Now) only NGS 3855 264 206
G406 Biological profiling of tumor (Caris Target Now) full profile 6000 411 215
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 75 938
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 190 13 022
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 190 13 022
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 160 10 966
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 160 10 966
G438 Immunohistochemical study of PDL-1 gene expression 165 11 308
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 899 61 614
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1550 106 230
G441 Comprehensive genetic study of thyroid tumors by NGS 1550 106 230
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 346 23 713
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 17 065
I504 Translocation in synovial sarcoma SYT/SSX 346 23 713
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 346 23 713

    Mobile application EMC